Near-patient Diagnostics Leverage Accel Diagnostics’ point-of-care platform to target healthcare providers and clinics seeking lab-quality testing with rapid turnaround, especially in urgent care, telemedicine, and rural or underserved markets where access to centralized labs is limited.

Small Company Advantage Position as a nimble, customer-focused partner for early adopters and pilot programs, offering flexible engagements, rapid iteration, and personalized support that larger labs struggle to provide at scale.

COVID Lab Footprint Capitalize on the ADX Diagnostic Lab experience from the COVID-19 era to offer scalable testing capacity for surges, routine screening, and outbreak response, targeting clinics, schools, and corporate wellness programs needing reliable on-site or near-site testing.

Strategic Partnerships Explore collaborations with mid-market reference labs and regional hospital networks that lack in-house rapid testing capabilities, providing integration support, data interoperability, and co-marketing to expand reach.

Affordability and Speed Highlight the technology’s potential to reduce time-to-result and overall care costs compared to traditional lab-based diagnostics, appealing to value-focused health systems, payers, and employers seeking cost-effective health monitoring solutions.